Methyl 2-(1-ethylpiperidin-4-yl)acetate, 97%, 250mg

OKANIN, 95%, 5mg

(S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)butanoic acid, 97%, 250mg

1-Piperidinepropionic acid, 95.0%, 1g

(S)-1-Naphthalen-1-yl-ethanol, 97.0%, 5g

N-(tert-Butoxycarbonyl)-S-benzyl-L-cysteine>98.0%(HPLC)(T)5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)but-3-enoic acid, 98%, 500mg

2-Cyano-4-methylbenzoic acid, 98%, 1g

6-methyl-1H-imidazo[1,2-b]pyrazole, 95.0%, 250mg

(6-Morpholin-4-yl-3-nitro-4-trifluoromethyl-pyridin-2-ylsulfanyl)-acetic acid methyl ester, 95.0%, 1g

(R)-2-Amino-2-(pyridin-2-yl)ethan-1-ol dihydrochloride, 97%, 5g

5,10-Dihydroindolo[3,2-b]indole, 95.0%, 250mg

1,3-bis(4-bromophenyl)propane-1,3-dione, 1g